REGULATED PRESS RELEASE published on 09/23/2024 at 18:50, 1 month 27 days ago First half Results: Active management and increased investment capacity Peugeot Invest reports active management and increased investment capacity in H1 2024, with CEO appointment and net profit of €228 million. NAV per-share €226.7, -3.7% from last year PEUGEOT INVEST CEO Appointment Net Profit Investment Capacity NAV Per-share
BRIEF published on 09/04/2024 at 17:40, 2 months 16 days ago Peugeot Invest - Number of shares and voting rights as of August 31, 2024 Voting Rights PEUGEOT INVEST Actions Regulation Thresholds
BRIEF published on 08/05/2024 at 17:51, 3 months 15 days ago Peugeot Invest: Declaration of the number of shares and voting rights Voting Rights Eurolist Peugeot Shares Legal Declaration Participation Threshold
BRIEF published on 07/24/2024 at 18:25, 3 months 27 days ago Jean-Charles Douin Appointed CEO of Peugeot Invest Private Equity PEUGEOT INVEST CEO Appointment Leadership Change Jean-Charles Douin
REGULATED PRESS RELEASE published on 07/24/2024 at 18:20, 3 months 27 days ago Jean-Charles Douin appointed CEO of Peugeot Invest Jean-Charles Douin appointed CEO of Peugeot Invest. With 20 years in private equity, he brings vast experience to lead the company's growth strategy Growth Strategy Private Equity PEUGEOT INVEST CEO Appointment Jean-Charles Douin
BRIEF published on 07/17/2024 at 17:50, 4 months 3 days ago Peugeot Invest Discloses Trading in Own Shares Annual General Meeting Euronext PEUGEOT INVEST Investment Share Trading
REGULATED PRESS RELEASE published on 07/17/2024 at 17:45, 4 months 3 days ago Disclosure of trading in own shares Peugeot Invest discloses trading in own shares between 8 and 10 July 2024, authorized by AGM. Company listed on Euronext reveals details of transactions Euronext PEUGEOT INVEST Trading Disclosure Own Shares
BRIEF published on 07/11/2024 at 17:50, 4 months 9 days ago Peugeot Invest Discloses Own Share Trading Euronext PEUGEOT INVEST Financial Disclosure Share Trading
REGULATED PRESS RELEASE published on 07/11/2024 at 17:45, 4 months 9 days ago Disclosure of trading in own shares Disclosure of trading in own shares by Peugeot Invest under authorization from AGM for July 2024. Detailed info available on website. Peugeot Invest: investment firm on Euronext Euronext PEUGEOT INVEST Trading Investment Company Own Shares
BRIEF published on 07/05/2024 at 18:12, 4 months 15 days ago Peugeot Invest Increases Resources for Liquidity Contract Liquidity Contract PEUGEOT INVEST Investment ODDO BHF AMF Decision
Published on 11/21/2024 at 13:30, 30 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 30 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 25 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 45 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 2 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 40 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 15 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 15 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
